TY - JOUR
T1 - The relationship of PrEP beliefs to perceived personal, interpersonal and structural benefits and barriers to PrEP use in women who inject drugs
AU - Paulus, Kirsten
AU - Kelly, Patrick J.A.
AU - Brajuha, Jesse
AU - D’Avanzo, Paul
AU - Dauria, Emily F.
AU - Trainor, Aurora
AU - Alrez, Annabelle
AU - Bass, Sarah Bauerle
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/5/8
Y1 - 2023/5/8
N2 - Background: Women who inject drugs (WWID) have significant biological, behavioral, and gender-based barriers to accessing HIV prevention services, including Pre-Exposure Prophylaxis (PrEP) medication. Little is known about how beliefs about PrEP impact both perceived barriers and benefits of PrEP use and how they may be related to the decision-making process. Methods: Surveys were conducted with 100 female clients of a large syringe services program in Philadelphia, Pennsylvania. The sample was categorized into three groups based on mean PrEP beliefs scores using terciles: accurate beliefs, moderately accurate beliefs, and inaccurate beliefs. Oneway ANOVA tests were used to compare groups by perceived benefits and barriers to PrEP, drug use stigma, healthcare beliefs, patient self-advocacy, and intention to use PrEP. Results: Participants had a mean age of 39 years (SD 9.00), 66% reported being White, 74% finished high school, and 80% reported having been homeless within the past 6 months. Those with the most accurate PrEP beliefs reported highest intent to use PrEP and were more likely to agree that benefits of PrEP included it preventing HIV and helping them “feel in charge”. Those with inaccurate beliefs were more likely to strongly agree that barriers, such as fear of reprisal from a partner, potential theft, or feeling they “might get HIV anyway”, were reasons not to use PrEP. Conclusions: Results indicate perceived personal, interpersonal and structural barriers to PrEP use are associated with accuracy of beliefs is, pointing to important intervention targets to increase uptake among WWID.
AB - Background: Women who inject drugs (WWID) have significant biological, behavioral, and gender-based barriers to accessing HIV prevention services, including Pre-Exposure Prophylaxis (PrEP) medication. Little is known about how beliefs about PrEP impact both perceived barriers and benefits of PrEP use and how they may be related to the decision-making process. Methods: Surveys were conducted with 100 female clients of a large syringe services program in Philadelphia, Pennsylvania. The sample was categorized into three groups based on mean PrEP beliefs scores using terciles: accurate beliefs, moderately accurate beliefs, and inaccurate beliefs. Oneway ANOVA tests were used to compare groups by perceived benefits and barriers to PrEP, drug use stigma, healthcare beliefs, patient self-advocacy, and intention to use PrEP. Results: Participants had a mean age of 39 years (SD 9.00), 66% reported being White, 74% finished high school, and 80% reported having been homeless within the past 6 months. Those with the most accurate PrEP beliefs reported highest intent to use PrEP and were more likely to agree that benefits of PrEP included it preventing HIV and helping them “feel in charge”. Those with inaccurate beliefs were more likely to strongly agree that barriers, such as fear of reprisal from a partner, potential theft, or feeling they “might get HIV anyway”, were reasons not to use PrEP. Conclusions: Results indicate perceived personal, interpersonal and structural barriers to PrEP use are associated with accuracy of beliefs is, pointing to important intervention targets to increase uptake among WWID.
KW - Adult
KW - Anti-HIV Agents/therapeutic use
KW - Female
KW - HIV Infections/prevention & control
KW - Humans
KW - Intention
KW - Pennsylvania
KW - Pre-Exposure Prophylaxis/methods
KW - Social Stigma
UR - http://www.scopus.com/inward/record.url?scp=85161399877&partnerID=8YFLogxK
U2 - 10.1186/s12905-023-02452-7
DO - 10.1186/s12905-023-02452-7
M3 - Article
C2 - 37291563
AN - SCOPUS:85161399877
SN - 1472-6874
VL - 23
SP - 303
JO - BMC Women's Health
JF - BMC Women's Health
IS - 1
M1 - 303
ER -